REZOLUTE, INC. Line of Credit Facility, Interest Rate During Period
REZOLUTE, INC. (RZLT) reported Line of Credit Facility, Interest Rate During Period of 5.00% for the 9-month period ending 2014-03-31, per its 10-Q filed 2014-05-14.
Discontinued › Notes › Debt › Line of Credit Facility
us-gaap:LineOfCreditFacilityInterestRateDuringPeriod · last filed 2014-09-30
| Period end | Line of Credit Facility, Interest Rate During Period 1 month | Line of Credit Facility, Interest Rate During Period 9 month | Line of Credit Facility, Interest Rate During Period 12 month |
|---|---|---|---|
| 2014-03-31 | 5.00% 10-Q · filed 2014-05-14 | ||
| 2012-12-31 | 5.00% 10-K · filed 2014-09-30 | 5.00% 10-Q · filed 2014-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |